Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002528334 | SCV000633377 | likely benign | Familial cancer of breast | 2024-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016600 | SCV001177566 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001016600 | SCV001339500 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490997 | SCV002796723 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000547116 | SCV004222316 | likely benign | not provided | 2022-11-03 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000547116 | SCV001193287 | uncertain significance | not provided | 2018-08-25 | no assertion criteria provided | curation | Curators: Marc Tischkowitz, Arleen D. Auerbach. Submitter to LOVD: Yukihide Momozawa. |